Avian Sarcoma and Leukemia Virus (ASLV) integration in vitro: Mutation or deletion of integrase (IN) recognition sequences does not prevent but only reduces the efficiency and accuracy of DNA integration

Virology

Volumn 392, Issue 1, 2009, Pages 94-102

  Moreau, Karen ^a,b,c,d,e   Charmetant, Julie ^f   Gallay, Kathy ^a,b,c,d,e   Faure, Claudine ^b,c   Verdier, Gérard ^a,b,c,d,e   Ronfort, Corinne ^a,b,c,d,e  

^a UMR 754   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITÉ LYON 1   (France)

^d IFR 128   (France)

^e VETAGRO SUP   (France)

^f Biomatech   (France)

Author keywords

Avian Sarcoma and Leukemia Viruses; Concerted DNA integration; IN recognition sequences; Retroviral integration

Indexed keywords

INTEGRASE;

ACCURACY; ARTICLE; AVIAN LEUKOSIS ONCOVIRUS; AVIAN SARCOMA VIRUS; ENZYME SUBSTRATE; GENE DELETION; GENE DUPLICATION; GENE SEQUENCE; IN VITRO STUDY; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS DNA CELL DNA INTERACTION;

AVES;

EID: 69349084931     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.06.031     Document Type: Article

References (42)

1. Aiyar A., Hindmarsh P., Skalka A.M., and Leis J. Concerted integration of linear retroviral DNA by the avian sarcoma virus integrase in vitro: dependence on both long terminal repeat termini. J. Virol. 70 6 (1996) 3571-3580
2. Bera S., Vora A.C., Chiu R., Heyduk T., and Grandgenett D.P. Synaptic complex formation of two retrovirus DNA attachment sites by integrase: a fluorescence energy transfer study. Biochemistry 44 46 (2005) 15106-15114
3. Brin E., and Leis J. Changes in the mechanism of DNA integration in vitro induced by base substitutions in the HIV-1 U5 and U3 terminal sequences. J. Biol. Chem. 277 13 (2002) 10938-10948
4. Brin E., and Leis J. HIV-1 integrase interaction with U3 and U5 terminal sequences in vitro defined using substrates with random sequences. J. Biol. Chem. 277 21 (2002) 18357-18364
5. Brown P.O. Integration. In: Coffin J.M., Hugues S.H., and Varmus H.E. (Eds). Retroviruses (1997), Cold Spring Harbor Laboratory Press, Cold spring Harbor, New York 161-204
6. Chen H., and Engelman A. Asymmetric processing of human immunodeficiency virus type 1 cDNA in vivo: implications for functional end coupling during the chemical steps of DNA transposition. Mol. Cell. Biol. 21 20 (2001) 6758-6767
7. Chiu R., and Grandgenett D.P. Avian retrovirus DNA internal attachment site requirements for full-site integration in vitro. J. Virol. 74 18 (2000) 8292-8298
8. Chiu R., and Grandgenett D.P. Molecular and genetic determinants of Rous sarcoma virus integrase for concerted DNA integration. J. Virol. 77 11 (2003) 6482-6492
9. Craigie R., Fujiwara T., and Bushman F. The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro. Cell 62 4 (1990) 829-837
10. Faure A., Calmels C., Desjobert C., Castroviejo M., Caumont-Sarcos A., Tarrago-Litvak L., Litvak S., and Parissi V. HIV-1 integrase crosslinked oligomers are active in vitro. Nucleic Acids Res. 33 3 (2005) 977-986
11. Grandgenett D.P., Bera S., Pandey K.K., Vora A.C., Zahm J., and Sinha S. Biochemical and biophysical analyses of concerted (U5/U3) integration. Methods (2009) 47 (4), 229-236
12. Guiot E., Carayon K., Delelis O., Simon F., Tauc P., Zubin E., Gottikh M., Mouscadet J.F., Brochon J.C., and Deprez E. Relationship between the oligomeric status of HIV-1 integrase on DNA and enzymatic activity. J. Biol. Chem. 281 32 (2006) 22707-22719
13. Hindmarsh P., Johnson M., Reeves R., and Leis J. Base-pair substitutions in avian sarcoma virus U5 and U3 long terminal repeat sequences alter the process of DNA integration in vitro. J. Virol. 75 3 (2001) 1132-1141
14. Hindmarsh P., and Leis J. Reconstitution of concerted DNA integration with purified components. Adv. Virus Res. 52 (1999) 397-410
15. Hindmarsh P., Ridky T., Reeves R., Andrake M., Skalka A.M., and Leis J. HMG protein family members stimulate human immunodeficiency virus type 1 and avian sarcoma virus concerted DNA integration in vitro. J. Virol. 73 4 (1999) 2994-3003
16. Hughes S.H., Mutschler A., Bishop J.M., and Varmus H.E. A Rous sarcoma virus provirus is flanked by short direct repeats of a cellular DNA sequence present in only one copy prior to integration. Proc. Natl. Acad. Sci. U. S. A. 78 7 (1981) 4299-4303
17. Ju G., Boone L., and Skalka A.M. Isolation and characterization of recombinant DNA clones of avian retroviruses: size heterogeneity and instability of the direct repeat. J. Virol. 33 3 (1980) 1026-1033
18. Juretzek T., Holm T., Gartner K., Kanzler S., Lindemann D., Herchenroder O., Picard-Maureau M., Rammling M., Heinkelein M., and Rethwilm A. Foamy virus integration. J. Virol. 78 5 (2004) 2472-2477
19. Katzman M., Katz R.A., Skalka A.M., and Leis J. The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration. J. Virol. 63 12 (1989) 5319-5327
20. Katz R.A., Merkel G., Kulkosky J., Leis J., and Skalka A.M. The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro. Cell 63 1 (1990) 87-95
21. Katz R.A., DiCandeloro P., Kukolj G., and Skalka A.M. Role of DNA end distortion in catalysis by avian sarcoma virus integrase. J. Biol. Chem. 276 36 (2001) 34213-34220
22. Masuda T., Kuroda M.J., and Harada S. Specific and independent recognition of U3 and U5 att sites by human immunodeficiency virus type 1 integrase in vivo. J. Virol. 72 10 (1998) 8396-8402
23. McCord M., Chiu R., Vora A.C., and Grandgenett D.P. Retrovirus DNA termini bound by integrase communicate in trans for full-site integration in vitro. Virology 259 2 (1999) 392-401
24. Moreau K., Torne-Celer C., Faure C., Verdier G., and Ronfort C. In vivo retroviral integration: fidelity to size of the host DNA duplication might be reduced when integration occurs near sequences homologous to LTR ends. Virology 278 1 (2000) 133-136
25. Moreau K., Faure C., Verdier G., and Ronfort C. Analysis of conserved and non-conserved amino acids critical for ALSV (Avian Leukemia And Sarcoma Viruses) integrase functions in vitro. Arch. Virol. 147 9 (2002) 1761-1778
26. Moreau K., Faure C., Violot S., Verdier G., and Ronfort C. Mutations in the C-terminal domain of ALSV (Avian Leukemia and Sarcoma Viruses) integrase alter the concerted DNA integration process in vitro. Eur. J. Biochem. 270 22 (2003) 4426-4438
27. Moreau K., Faure C., Violot S., Gouet P., Verdier G., and Ronfort C. Mutational analyses of the core domain of Avian Leukemia and Sarcoma Viruses integrase: critical residues for concerted integration and multimerization. Virology 318 2 (2004) 566-581
28. Mules E.H., Uzun O., and Gabriel A. In vivo Ty1 reverse transcription can generate replication intermediates with untidy ends. J. Virol. 72 8 (1998) 6490-6503
29. Murphy J.E., and Goff S.P. A mutation at one end of Moloney murine leukemia virus DNA blocks cleavage of both ends by the viral integrase in vivo. J. Virol. 66 8 (1992) 5092-5095
30. Oh J., Chang K.W., Alvord W.G., and Hughes S.H. Alternate polypurine tracts affect Rous sarcoma virus integration in vivo. J. Virol. 80 20 (2006) 10281-10284
31. Oh J., Chang K.W., and Hughes S.H. Mutations in the U5 sequences adjacent to the primer binding site do not affect tRNA cleavage by Rous sarcoma virus RNase H but do cause aberrant integrations in vivo. J. Virol. 80 1 (2006) 451-459
32. Oh J., Chang K.W., and Hughes S.H. Integration of Rous sarcoma virus DNA: a CA dinucleotide is not required for integration of the U3 end of viral DNA. J. Virol. 82 22 (2008) 11480-11483
33. Oh J., Chang K.W., Wierzchoslawski R., Alvord W.G., and Hughes S.H. Rous sarcoma virus (RSV) integration in vivo: a CA dinucleotide is not required in U3, and RSV linear DNA does not autointegrate. J. Virol. 82 1 (2008) 503-512
34. Scottoline B.P., Chow S., Ellison V., and Brown P.O. Disruption of the terminal base pairs of retroviral DNA during integration. Genes Dev. 11 3 (1997) 371-382
35. Sinha S., Pursley M.H., and Grandgenett D.P. Efficient concerted integration by recombinant human immunodeficiency virus type 1 integrase without cellular or viral cofactors. J. Virol. 76 7 (2002) 3105-3113
36. Smith J.A., and Daniel R. Following the path of the virus: the exploitation of host DNA repair mechanisms by retroviruses. ACS Chem. Biol. 1 4 (2006) 217-226
37. Vora A., and Grandgenett D.P. DNase protection analysis of retrovirus integrase at the viral DNA ends for full-site integration in vitro. J. Virol. 75 8 (2001) 3556-3567
38. Vora A., Bera S., and Grandgenett D. Structural organization of avian retrovirus integrase in assembled intasomes mediating full-site integration. J. Biol. Chem. 279 18 (2004) 18670-18678
39. Vora A.C., and Grandgenett D.P. Assembly and catalytic properties of retrovirus integrase-DNA complexes capable of efficiently performing concerted integration. J. Virol. 69 12 (1995) 7483-7488
40. Vora A.C., McCord M., Fitzgerald M.L., Inman R.B., and Grandgenett D.P. Efficient concerted integration of retrovirus-like DNA in vitro by avian myeloblastosis virus integrase. Nucleic Acids Res. 22 21 (1994) 4454-4461
41. Vora A.C., Chiu R., McCord M., Goodarzi G., Stahl S.J., Mueser T.C., Hyde C.C., and Grandgenett D.P. Avian retrovirus U3 and U5 DNA inverted repeats. Role of nonsymmetrical nucleotides in promoting full-site integration by purified virion and bacterial recombinant integrases. J. Biol. Chem. 272 38 (1997) 23938-23945
42. Wei S.Q., Mizuuchi K., and Craigie R. Footprints on the viral DNA ends in Moloney murine leukemia virus preintegration complexes reflect a specific association with integrase. Proc. Natl. Acad. Sci. U. S. A. 95 18 (1998) 10535-10540